Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses
NCT ID: NCT00613184
Last Updated: 2008-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2006-11-30
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
NCT05864118
Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior
NCT05043623
Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic
NCT04368260
Comparison Between Different Sampling Sites for Detection of Respiratory Viruses
NCT06743750
Sample Collection to Evaluate an Investigational Instrument for the Detection of Respiratory Viruses in Nasopharyngeal Swabs
NCT01806285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nylon flocked swabs (NFS) and universal transport medium for room temperature (UTM-RT) (Copan Medical, Murrieta, CA) storage media have been found to be an effective collection and transport method for bacteria causing sexually transmitted infections.
We adapted these swabs and storage medium to collect respiratory viruses from children less than18 months old and compared detection rates using NFS and traditional nasal aspirates. We will determine the relative roles of the UTM-RT and NFS release and therefore measured viral detection rates of common respiratory pathogens in traditional saline aspirates stored in UTM-RT.
Our primary hypothesis is that nasal secretions collection using NFS stored in UTM-RT will lead to a higher detection rate of the respiratory viruses we arestudying; namely RSV, Influenza and human metapneumovirus from than collection of unpreserved saline nasal aspirates in children less than 18 months of age.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Nylon Flocked swab Left Nasal Wash right
Nylon Flocked swab (Nasal secretion sampling)
Nasal Aspirate Nylon Flocked swab
Nylon Flocked swab (Nasal secretion sampling)
Nylon flocked swab Nasal Wash
2
Nylon Flocked swab R Nasal Wash L
Nylon Flocked swab (Nasal secretion sampling)
Nasal Aspirate Nylon Flocked swab
3
Nasal Wash Left Nylon Flocked swab Right
Nylon Flocked swab (Nasal secretion sampling)
Nasal Aspirate Nylon Flocked swab
4
Nasal Wash R Nylon flocked swab L
Nylon Flocked swab (Nasal secretion sampling)
Nasal Aspirate Nylon Flocked swab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nylon Flocked swab (Nasal secretion sampling)
Nasal Aspirate Nylon Flocked swab
Nylon Flocked swab (Nasal secretion sampling)
Nylon flocked swab Nasal Wash
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Age \> 18 months
18 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Diagnostic Laboratories, LLC
INDUSTRY
Copan Innovation Murrietta, CA
UNKNOWN
Kern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Emergency Medicine, Kern Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Walsh, MD
Role: PRINCIPAL_INVESTIGATOR
Kern Medical Center & David Geffen School of Medicine UCLA
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kmc06037
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.